FR2444462A1 - COMPOSITIONS FOR CONTROLLING HYPERTENSION AND INTESTINAL DISORDERS COMPRISING AN N-ARYL N'2- (IMIDAZOLIDINYLIDENE) -URA DERIVATIVE - Google Patents

COMPOSITIONS FOR CONTROLLING HYPERTENSION AND INTESTINAL DISORDERS COMPRISING AN N-ARYL N'2- (IMIDAZOLIDINYLIDENE) -URA DERIVATIVE

Info

Publication number
FR2444462A1
FR2444462A1 FR7931473A FR7931473A FR2444462A1 FR 2444462 A1 FR2444462 A1 FR 2444462A1 FR 7931473 A FR7931473 A FR 7931473A FR 7931473 A FR7931473 A FR 7931473A FR 2444462 A1 FR2444462 A1 FR 2444462A1
Authority
FR
France
Prior art keywords
imidazolidinylidene
ura
compositions
aryl
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7931473A
Other languages
French (fr)
Other versions
FR2444462B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
McNeilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/972,579 external-priority patent/US4229462A/en
Priority claimed from US05/972,580 external-priority patent/US4239768A/en
Application filed by McNeilab Inc filed Critical McNeilab Inc
Publication of FR2444462A1 publication Critical patent/FR2444462A1/en
Application granted granted Critical
Publication of FR2444462B1 publication Critical patent/FR2444462B1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30—Isothioureas
    • C07C335/38—Isothioureas containing any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne de nouvelles compositions pharmaceutiques. Celles-ci contiennent à titre d'ingrédient actif un composé de formule :The invention relates to novel pharmaceutical compositions. These contain as active ingredient a compound of formula:

FR7931473A 1978-12-22 1979-12-21 COMPOSITIONS FOR CONTROLLING HYPERTENSION AND INTESTINAL DISORDERS COMPRISING AN N-ARYL N'2- (IMIDAZOLIDINYLIDENE) -URA DERIVATIVE Expired FR2444462B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/972,579 US4229462A (en) 1978-12-22 1978-12-22 Method for controlling hypertension and compositions
US05/972,580 US4239768A (en) 1978-12-22 1978-12-22 Method for relieving irritable bowel syndrome symptoms

Publications (2)

Publication Number Publication Date
FR2444462A1 true FR2444462A1 (en) 1980-07-18
FR2444462B1 FR2444462B1 (en) 1986-08-29

Family

ID=27130555

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7931473A Expired FR2444462B1 (en) 1978-12-22 1979-12-21 COMPOSITIONS FOR CONTROLLING HYPERTENSION AND INTESTINAL DISORDERS COMPRISING AN N-ARYL N'2- (IMIDAZOLIDINYLIDENE) -URA DERIVATIVE
FR8007757A Expired FR2445321B1 (en) 1978-12-22 1980-04-04

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR8007757A Expired FR2445321B1 (en) 1978-12-22 1980-04-04

Country Status (23)

Country Link
AT (1) AT373878B (en)
AU (2) AU532332B2 (en)
CA (1) CA1127651A (en)
CH (1) CH647236A5 (en)
DE (1) DE2951213A1 (en)
DK (1) DK548179A (en)
ES (1) ES8101558A1 (en)
FI (1) FI66354C (en)
FR (2) FR2444462B1 (en)
GB (2) GB2040681B (en)
GR (1) GR68018B (en)
HU (1) HU183013B (en)
IL (1) IL59019A (en)
IT (1) IT1126839B (en)
NL (1) NL7909265A (en)
NO (1) NO794249L (en)
NZ (1) NZ192453A (en)
PH (1) PH16571A (en)
PT (1) PT70624A (en)
SE (1) SE7910612L (en)
SU (1) SU971098A3 (en)
YU (1) YU314979A (en)
ZW (1) ZW25379A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US11516649B2 (en) * 2018-10-29 2022-11-29 Apple Inc. Mechanism to activate and manage a standalone device for cellular service

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1296962A (en) * 1960-08-05 1962-06-22 Geigy Ag J R New 2-imino-1.3-di-aza compounds and their preparation
US3168520A (en) * 1960-08-05 1965-02-02 Geigy Chem Corp 2-imino-1, 3-disubstituted hexahydro-pyrimidines and imidazolidines

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1296962A (en) * 1960-08-05 1962-06-22 Geigy Ag J R New 2-imino-1.3-di-aza compounds and their preparation
US3168520A (en) * 1960-08-05 1965-02-02 Geigy Chem Corp 2-imino-1, 3-disubstituted hexahydro-pyrimidines and imidazolidines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ARZNEIMITTEL-FORSCHUNG,vol. 28, no. 8a, août 1978, pages 1435-1441, Aulendorf (DE); *
THE MERCK INDEX, An Encyclopedia of Chemicals and Drugs, 9e édition, 1976, Merck & Co., Inc., Rahway, N.Y. (USA); *

Also Published As

Publication number Publication date
FR2444462B1 (en) 1986-08-29
FR2445321B1 (en) 1983-08-26
CA1127651A (en) 1982-07-13
AT373878B (en) 1984-02-27
GB2040681B (en) 1983-04-13
DK548179A (en) 1980-06-23
ES487159A0 (en) 1980-12-16
NL7909265A (en) 1980-06-24
GB2113204B (en) 1984-02-01
PH16571A (en) 1983-11-18
GB2113204A (en) 1983-08-03
IL59019A0 (en) 1980-03-31
DE2951213A1 (en) 1980-07-10
GB2040681A (en) 1980-09-03
FI66354B (en) 1984-06-29
IT7951164A0 (en) 1979-12-21
AU1640083A (en) 1983-11-17
YU314979A (en) 1983-02-28
AU5378079A (en) 1980-06-26
IL59019A (en) 1984-05-31
SU971098A3 (en) 1982-10-30
HU183013B (en) 1984-04-28
SE7910612L (en) 1980-06-23
ZW25379A1 (en) 1981-07-22
FI794036A (en) 1980-06-23
NO794249L (en) 1980-06-24
FI66354C (en) 1984-10-10
ATA808979A (en) 1983-07-15
FR2445321A1 (en) 1980-07-25
NZ192453A (en) 1982-09-07
CH647236A5 (en) 1985-01-15
PT70624A (en) 1980-01-01
AU566013B2 (en) 1987-10-08
AU532332B2 (en) 1983-09-29
IT1126839B (en) 1986-05-21
GR68018B (en) 1981-10-27
ES8101558A1 (en) 1980-12-16

Similar Documents

Publication Publication Date Title
FR2356424A1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON PHOPHONOFORMIC ACID USEFUL IN THE FIGHT AGAINST VIRAL INFECTIONS
DK8885D0 (en) N-HETEROCYCLYL-4-PIPERIDINAMINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
IL97025A0 (en) 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them
ES479474A1 (en) Use of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3-beta-methoxy ethylester-5-isopropylester for the preparation of cerebrally active drugs.
FR2510888B1 (en) NOVEL COMPOSITIONS FOR PHARMACEUTICAL USE WITH PROLONGED EFFECT OF RELEASE OF AN ACTIVE INGREDIENT
FR2422657A1 (en) 2- (2-THENOYLTHIO) -PROPIONYLGLYCINE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
NO158379C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE NITROALIFATIC COMPOUNDS.
FR2405067A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING MONOFUNCTIONAL DERIVATIVES OF PSORALENE FOR THE TREATMENT OF SKIN DISORDERS
FR2381034A1 (en) ANALGESIC AND ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS BASED ON 1,3,5-TRIAZINE
FR2507605B1 (en) PROCESS FOR THE PREPARATION OF APOVINCAMINIC ACID ESTERS, ESTERS THUS OBTAINED AND PHARMACEUTICAL COMPOSITIONS PREPARED THEREWITH
FR2444462A1 (en) COMPOSITIONS FOR CONTROLLING HYPERTENSION AND INTESTINAL DISORDERS COMPRISING AN N-ARYL N'2- (IMIDAZOLIDINYLIDENE) -URA DERIVATIVE
FR2363324A1 (en) AQUEOUS OR HYDROALCOOLIC STABLE SOLUTIONS OF PERFUMED ESSENCES OR OIL SOLUBLE MEDICINAL PRODUCTS
FR2377804A1 (en) ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS CONTAINING CHROMONE DERIVATIVES
FR2361387A1 (en) DERMATOLOGICAL COMPOSITION
FR2430230A1 (en) MEDICINES BASED ON ANTHRANILIC ACID DERIVATIVES
ATE123487T1 (en) DERIVATIVES OF CAFEIC ACID AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
NO964497L (en) Means for the treatment of cor pulmonale
FR2404001A1 (en) OXAZOLIDONE-2 DERIVATIVES USEFUL AS MEDICINAL PRODUCTS AND METHODS FOR THEIR PREPARATION
FR2367056A1 (en) BIOCIDAL COMPOSITIONS BASED ON ARYL HYDRAZONE DERIVATIVES FOR THE CONTROL OF PLANT DISEASES
SE8001981L (en) COMPOSITIONS FOR TREATMENT OF GLAUCOM
FR2400505A1 (en) 1-ANTI-INFLAMMATORY PHENYLETHANOLAMINES, PHARMACEUTICAL COMPOSITIONS CONSISTING OF AND METHODS FOR PRODUCING THEM
BE901879A (en) ANALOGUE PRODUCTS OF 1ALPHA-HYDROXYVITAMIN D2, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2405948A1 (en) NEWS 4-PHENYL-THIENO- (2,3-C) - PIPERIDINES, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2433943A1 (en) DRUG PREPARATIONS ESPECIALLY FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
GB1500300A (en) Pharmaceutical preparation for the treatment of circulatory disorders

Legal Events

Date Code Title Description
ST Notification of lapse